Get the Stockscreener App
2.84
5.58%
0.15
After Hours:
2.84
Vistagen Therapeutics Inc Stock (VTGN) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
48.15%
0.4114
|
0.2777 | 0.0972 | 0.176 | 0.18 |
Operating Expenses
|
17.53%
8.2954
|
7.0579 | 7.1754 | 12.41 | 9.946 |
| Benefits Costs and Expenses |
1.52%
6.7612
|
6.8654 | 6.9978 | 12.40 | 9.941 |
| Costs And Expenses |
1.52%
6.7612
|
6.8654 | 6.9978 | 12.40 | 9.941 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
16.28%
-7.884
|
-6.7802 | -6.9978 | -12.24 | -9.766 |
| Net Interest Income/Expense |
696.99%
1.5342
|
0.1925 | 0.0972 | 0.013 | 0.005 |
| Interest Income/Expense After Provision For Losses |
696.99%
1.5342
|
0.1925 | 0.0972 | 0.013 | 0.005 |
| Income/Loss From Continuing Operations Before Tax |
3.61%
-6.3498
|
-6.5877 | -6.9006 | -12.23 | -9.761 |
| Income Tax Expense/Benefit |
-
|
- | 0.0025 | 0.001 | - |
| Income/Loss From Continuing Operations After Tax |
3.61%
-6.3498
|
-6.5877 | -6.9031 | -12.23 | -9.761 |
|
Net Income/Loss
|
3.61%
-6.3498
|
-6.5877 | -6.9031 | -12.23 | -9.761 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
192.64%
29.39
|
10.04 | 7.377 | 7.1638 | 6.8946 |
| Basic Earnings Per Share |
66.67%
-0.22
|
-0.66 | -0.94 | -1.71 | -1.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):